SUCCESS OF CHIMERIC ANTI-GD2 ANTIBODY+GM-CSF+IL2 IMMUNOTHERAPY IN HIGH-RISK NEUROBLASTOMA (NB) IN FIRST RESPONSE: A CRITICAL APPRAISAL
Conferences
London, WB; Sondel, P; Gilman, AL; Ozkaynak, F; Kreissman, S; Buxton, A; Chen, H; Matthay, KK; Cohn, SL; Maris, JM; Yu, AL
Published in: PEDIATRIC BLOOD & CANCER
November 2009
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
PEDIATRIC BLOOD & CANCER
ISSN
1545-5009
Publication Date
November 2009
Volume
53
Issue
5
Start / End Page
708 / 708
Related Subject Headings
- Oncology & Carcinogenesis
- 3213 Paediatrics
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
London, W. B., Sondel, P., Gilman, A. L., Ozkaynak, F., Kreissman, S., Buxton, A., … Yu, A. L. (2009). SUCCESS OF CHIMERIC ANTI-GD2 ANTIBODY+GM-CSF+IL2 IMMUNOTHERAPY IN HIGH-RISK NEUROBLASTOMA (NB) IN FIRST RESPONSE: A CRITICAL APPRAISAL. In PEDIATRIC BLOOD & CANCER (Vol. 53, pp. 708–708).
London, Wendy B., Paul Sondel, Andrew L. Gilman, Fevzi Ozkaynak, Susan Kreissman, Allen Buxton, Helen Chen, et al. “SUCCESS OF CHIMERIC ANTI-GD2 ANTIBODY+GM-CSF+IL2 IMMUNOTHERAPY IN HIGH-RISK NEUROBLASTOMA (NB) IN FIRST RESPONSE: A CRITICAL APPRAISAL.” In PEDIATRIC BLOOD & CANCER, 53:708–708, 2009.
London WB, Sondel P, Gilman AL, Ozkaynak F, Kreissman S, Buxton A, et al. SUCCESS OF CHIMERIC ANTI-GD2 ANTIBODY+GM-CSF+IL2 IMMUNOTHERAPY IN HIGH-RISK NEUROBLASTOMA (NB) IN FIRST RESPONSE: A CRITICAL APPRAISAL. In: PEDIATRIC BLOOD & CANCER. 2009. p. 708–708.
London, Wendy B., et al. “SUCCESS OF CHIMERIC ANTI-GD2 ANTIBODY+GM-CSF+IL2 IMMUNOTHERAPY IN HIGH-RISK NEUROBLASTOMA (NB) IN FIRST RESPONSE: A CRITICAL APPRAISAL.” PEDIATRIC BLOOD & CANCER, vol. 53, no. 5, 2009, pp. 708–708.
London WB, Sondel P, Gilman AL, Ozkaynak F, Kreissman S, Buxton A, Chen H, Matthay KK, Cohn SL, Maris JM, Yu AL. SUCCESS OF CHIMERIC ANTI-GD2 ANTIBODY+GM-CSF+IL2 IMMUNOTHERAPY IN HIGH-RISK NEUROBLASTOMA (NB) IN FIRST RESPONSE: A CRITICAL APPRAISAL. PEDIATRIC BLOOD & CANCER. 2009. p. 708–708.
Published In
PEDIATRIC BLOOD & CANCER
ISSN
1545-5009
Publication Date
November 2009
Volume
53
Issue
5
Start / End Page
708 / 708
Related Subject Headings
- Oncology & Carcinogenesis
- 3213 Paediatrics
- 3211 Oncology and carcinogenesis